Safety of contraceptives for young people


Everyone should have access to a wide range of safe, modern reproductive health supplies. Young people have unique needs and preferences, which should be met if they are to practice safe reproductive health choices. But how do we know for sure if RH products available today are safe for young people? How are young people, especially minors, included in clinical and behavioral trials of contraceptives? How do issues of consent and ethics impact product development? How are the hormonal levels and specific needs of young people taken into account?

This webinar asks seldom-heard questions and explores how to increase the availability of youth-centered RH supplies.

Topics & Speakers:

  • Welcome (Emilie Peeters, RHSC) 
  • Introduction on adolescents and young people as a key population for achieving FP2020 and universal goals and the need to design products that meet their needs (Clarissa Lord Brundage, The Bill and Melinda Gates Foundation)
  • Including minors in contraceptive clinical and behavior trials (Prof. Melissa Gilliam, University of Chicago) 
  • Informed consent and ethics (John Townsend, Population Council) - Q&A (moderated by Emilie Peeters, RHSC)
You are currently offline. Some pages or content may fail to load.